Derek C Angus,Alison J Huang,Roger J Lewis,Amy P Abernethy,Robert M Califf,Martin Landray,Nancy Kass,Kirsten Bibbins-Domingo,JAMA Summit on Clinical Trials Participants,Ali B Abbasi,Kaleab Z Abebe,Stacey J Adam,Jamy Ard,Rachel A Bender Ignacio,Scott M Berry,Deepak L Bhatt,Robert O Bonow,Marc Bonten,Sharon A Brangman,John Brownstein,Melinda J B Buntin,Atul J Butte,Marion K Campbell,Anne R Cappola,Anne C Chiang,Deborah Cook,Steven R Cummings,Gregory Curfman,Laura J Esserman,Lee A Fleisher,Joseph B Franklin,Ralph Gonzalez,Cynthia I Grossman,Tufia C Haddad,Roy S Herbst,Adrian F Hernandez,Diane P Holder,Leora Horn,Grant D Huang,Alison Huang,Rohan Khera,Walter J Koroshetz,Harlan M Krumholz,Tracy A Lieu,Preeti N Malani,Christa Lese Martin,Mark McClellan,Mary M McDermott,Stephanie R Morain,Susan A Murphy,Stuart G Nicholls,Stephen J Nicholls,Peter J O'Dwyer,Bhakti K Patel,Eric Peterson,Sheila A Prindiville,Joseph S Ross,Kathryn M Rowan,Gordon Rubenfeld,Christopher W Seymour,Rod S Taylor,Joanne Waldstreicher,Tracy Y Wang

Abstract:Importance: Optimal health care delivery, both now and in the future, requires a continuous loop of knowledge generation, dissemination, and uptake on how best to provide care, not just determining what interventions work but also how best to ensure they are provided to those who need them. The randomized clinical trial (RCT) is the most rigorous instrument to determine what works in health care. However, major issues with both the clinical trials enterprise and the lack of integration of clinical trials with health care delivery compromise medicine's ability to best serve society. Observations: In most resource-rich countries, the clinical trials and health care delivery enterprises function as separate entities, with siloed goals, infrastructure, and incentives. Consequently, RCTs are often poorly relevant and responsive to the needs of patients and those responsible for care delivery. At the same time, health care delivery systems are often disengaged from clinical trials and fail to rapidly incorporate knowledge generated from RCTs into practice. Though longstanding, these issues are more pressing given the lessons learned from the COVID-19 pandemic, heightened awareness of the disproportionate impact of poor access to optimal care on vulnerable populations, and the unprecedented opportunity for improvement offered by the digital revolution in health care. Four major areas must be improved. First, especially in the US, greater clarity is required to ensure appropriate regulation and oversight of implementation science, quality improvement, embedded clinical trials, and learning health systems. Second, greater adoption is required of study designs that improve statistical and logistical efficiency and lower the burden on participants and clinicians, allowing trials to be smarter, safer, and faster. Third, RCTs could be considerably more responsive and efficient if they were better integrated with electronic health records. However, this advance first requires greater adoption of standards and processes designed to ensure health data are adequately reliable and accurate and capable of being transferred responsibly and efficiently across platforms and organizations. Fourth, tackling the problems described above requires alignment of stakeholders in the clinical trials and health care delivery enterprises through financial and nonfinancial incentives, which could be enabled by new legislation. Solutions exist for each of these problems, and there are examples of success for each, but there is a failure to implement at adequate scale. Conclusions and relevance: The gulf between current care and that which could be delivered has arguably never been wider. A key contributor is that the 2 limbs of knowledge generation and implementation-the clinical trials and health care delivery enterprises-operate as a house divided. Better integration of these 2 worlds is key to accelerated improvement in health care delivery.

Embedding routine health care data in clinical trials: with great power comes great responsibility

Building a patient-centred nationwide integrated cardiac care registry: intermediate results from the Netherlands

Sharing Medical Big Data While Preserving Patient Confidentiality in Innovative Medicines Initiative: A Summary and Case Report from BigData@Heart

Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage

The use of routinely collected healthcare records for outcome assessment in clinical trials: a UK perspective

Digitizing clinical trials

Optimizing data integration in trials that use EHR data: lessons learned from a multi-center randomized clinical trial

The use of healthcare systems data for RCTs

Linking clinical trial participants to their U.S. real-world data through tokenization: A practical guide

Feasibility of structuring electronic health record data to facilitate real‐world data research: ICAREdata methods applied to multicenter cancer clinical trials

Accuracy of heart failure ascertainment using routinely collected healthcare data: a systematic review and meta-analysis

Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?

Transportability of two heart failure trials to a disease registry using individual patient data.

Use cases of registry‐based randomized controlled trials—A review of the registries' contributions and constraints

Methodological Challenges using Routine Clinical Care Data for Real-World Evidence: a Rapid Review utilizing a systematic literature search and focus group discussion

Reuse of Routinely Collected Health Data for Clinical Research: Considerations in A Central England Case Study

Computational Phenomapping of Randomized Clinical Trials to Enable Assessment of their Real-world Representativeness and Personalized Inference

A study of implementation factors for a novel approach to clinical trials: constructs for consideration in the coordination of direct-to-patient online-based medical research

The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data

The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided

Feasibility of embedding orthopaedic clinical trials into national registries: a pilot quality improvement study for the UK Non-Arthroplasty Hip Registry (UK-NAHR)